A conformational rearrangement of the SARS-CoV-2 host protein sigma-1 is required for antiviral activity: insights from a combined in-silico/in-vitro approachSCIENTIFIC REPORTSIF3.92023-08-073OAAI
Deconstructing SARS-CoV-2 neutralization: A modular molecular framework for computational design and comparison of antibodies and nanobodies targeting the spike RBDJOURNAL OF MEDICAL VIROLOGYIF4.62023-06-205OA
Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM contextEPMA JOURNALIF5.92022-01-0635OAAI
Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodiesCELLULAR AND MOLECULAR LIFE SCIENCESIF6.22020-07-0498OAAI